Abstract:There is an increasing body of knowledge regarding how COVID-19 may be associated with ocular disease of varying severity and duration. This article discusses the literature on the ocular manifestations associated with COVID-19, including appraisal of the current evidence, suggested mechanisms of action, associated comorbidities and risk factors, timing from initial infection to diagnosis and clinical red flags. The current literature primarily comprises case reports and case series which inevitably lack control groups and evidence to support causality. However, these early data have prompted the development of larger population-based and laboratory studies that are emerging. As new data become available, a better appraisal of the true effects of COVID-19 on the eye will be possible. While the COVID-19 pandemic was officially declared no longer a "global health emergency" by the World Health Organization (WHO) in May 2023, case numbers continue to rise. Reinfection with different variants is predicted to lead to a growing cumulative burden of disease, particularly as more chronic, multi-organ sequelae become apparent with potentially significant ocular implications. COVID-19 ocular manifestations are postulated to be due to three main mechanisms: firstly, there is a dysregulated immune response to the initial infection linked to inflammatory eye disease; secondly, patients with COVID-19 have a greater tendency towards a hypercoagulable state, leading to prothrombotic events; thirdly, patients with severe COVID-19 requiring hospitalisation and are immunosuppressed due to administered corticosteroids or comorbidities such as diabetes mellitus are at an increased risk of secondary infections, including endophthalmitis and rhino-orbital-mucormycosis. Reported ophthalmic associations with COVID-19, therefore, include a range of conditions such as conjunctivitis, scleritis, uveitis, endogenous endophthalmitis, corneal graft rejection, retinal artery and vein occlusion, non-arteritic ischaemic optic neuropathy, glaucoma, neurological and orbital sequelae. With the need to consider telemedicine consultation in view of COVID-19's infectivity, understanding the range of ocular conditions that may present during or following infection is essential to ensure patients are appropriately triaged, with prompt in-person ocular examination for management of potentially sight-threatening and life-threatening diseases.

Ocular Implications of COVID-19 Infection and Vaccine-Related Adverse Events

Ocular manifestations of COVID-19

Update on Coronavirus Disease 2019: Ophthalmic Manifestations and Adverse Reactions to Vaccination.

COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19

The Review of Ophthalmic Symptoms in COVID-19

Ocular Involvement in COVID-19: Conjunctivitis and More

Ophthalmic Manifestations in COVID-19 Patients, a Review

Unraveling the Complexities of Severe Acute Respiratory Syndrome Coronavirus 2: A Comprehensive Ophthalmic and Systemic Perspective

Ocular Manifestations of COVID-19: A Systematic Review and Meta-analysis

Ocular manifestations in COVID-19 patients: A systematic review and meta-analysis.

Ophthalmic manifestations in the COVID-19 clinical spectrum

Pathogenesis of Vascular Retinal Manifestations in COVID-19 Patients: A Review

Management of COVID-19 in Ophthalmology

COVID-19 pandemic from an ophthalmology point of view

Evaluation of Ocular Symptoms and Tropism of SARS‐CoV‐2 in Patients Confirmed with COVID‐19

Ocular Complications after COVID-19 Vaccination, Vaccine Adverse Event Reporting System

Implications of COVID-19 for Ophthalmologists

COVID-19 Ocular Manifestations in the Early Phase of Disease

Ophthalmology-focused publications and findings on COVID-19: A systematic review

Ocular Involvement in Coronavirus Disease 2019: Up-to-Date Information on Its Manifestation, Testing, Transmission, and Prevention

Ocular inflammatory manifestations following COVID-19 vaccinations in Taiwan: A case series